E S Surrey

No ORCID on file · 16 papers in corpus · active 1989-1999

Study types

  • article 10
  • review 4
  • rct 2

Condition tags

  • endometriosis 12
  • mesh:D004715 11
  • infertility 2
  • mesh:D017699 1
review 1999
Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached?
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00500-7
review 1998
Add-Back Therapy: Extending Safety and Efficacy of GnRH Analogues in the Gynecologic Patient
Gynecologic and obstetric investigation ·doi:10.1159/000052849

GnRH analogues have been demonstrated to be effective medical therapy for symptomatic endometriosis. The use of these agents has been limited to 6 months due to hypoestrogenic side effects. A variety of steroidal and nonsteroidal add-back r…

article 1998
Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study
Obstetrics and gynecology ·doi:10.1016/s0029-7844(97)00620-0

OBJECTIVE: To evaluate the efficacy and safety of a GnRH agonist, leuprolide acetate depot, alone and in combination with three hormonal add-back regimens in the management of endometriosis-associated pelvic pain. METHODS: Two hundred and o…

rct 1995
Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy
Fertility and Sterility

OBJECTIVE: To examine the safety and efficacy of combining cyclic sodium etidronate and low-dose norethindrone with a long-acting GnRH agonist (GnRH-a) for prolonged therapy of symptomatic endometriosis. DESIGN: Prospective randomized open…

review 1995
Steroidal and nonsteroidal "add-back" therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient
Fertility and Sterility ·doi:10.1016/s0015-0282(16)57837-6

OBJECTIVE: To assess the efficacy of various steroidal and nonsteroidal add-back regimes in ameliorating hypoestrogenic side effects of long-term GnRH agonist (GnRH-a) therapy in gynecologic patients. DESIGN: English language literature re…

review 1994
Extending the use of gonadotropin-releasing hormone agonists: the emerging role of steroidal and nonsteroidal agents
Fertility and Sterility ·doi:10.1016/s0015-0282(16)56449-8

OBJECTIVE: To review and summarize the state of the art as it relates to the long-term application of GnRH agonists (GnRH-a). DESIGN: A retrospective analysis of the available literature and results and an up-to-date review of a rapidly ev…

rct 1993
Effects of sodium etidronate in combination with low-dose norethindrone in patients administered a long-acting GnRH agonist: a preliminary report
Obstetrics and gynecology

OBJECTIVE: To assess the efficacy of combining sodium etidronate with low doses of the 19-nor-testosterone progestin norethindrone or using high doses of norethindrone alone as prophylaxis against the vasomotor instability and bone density …

article 1993
The effect of growth factors on the proliferation of human endometrial stromal cells in culture
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(93)90356-n
article 1992
Direct effects of medroxyprogesterone acetate, danazol, and leuprolide acetate on endometrial stromal cell proliferation in vitro
Fertility and Sterility ·doi:10.1016/s0015-0282(16)55199-1
article 1992
Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial
·doi:10.1210/jc.75.2.558
article 1992
Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial.
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.75.2.1386374

The hypoestrogenic state induced by gonadotropin-releasing hormone agonists (GnRHa) has been shown to suppress symptomatic endometriosis effectively but to elicit vasomotor symptoms and loss of bone mineral density. The role of norethindron…

article 1991
Effect of platelet-derived growth factor on endometrial stromal cell proliferation in vitro: a model for endometriosis?
Fertility and Sterility ·doi:10.1016/s0015-0282(16)54598-1
article 1990
Effect of Peritoneal Fluid From Endometriosis Patients on Endometrial Stromal Cell Proliferation In Vitro
Obstetrics and gynecology ·doi:10.1097/00006250-199011000-00013

Late proliferative phase endometrial stromal cells grown in short-term culture were used as a model for the stromal component of endometriotic implants. Cells were grown in medium alone and in medium supplemented by 5, 10, and 20% concentra…

article 1990
Endometriosis and infertility: the mechanisms involved.
Progress in clinical and biological research
article 1990
The effects of combining norethindrone with a gonadotropin‐releasing hormone agonist in the treatment of symptomatic endometriosis
Fertility and Sterility ·doi:10.1016/0020-7292(90)90540-2

Treatment of endometriosis with gonadotropin-releasing hormone agonists (GnRH-a) is associated with side effects secondary to the induced hypoestrogenic state. In an effort to ameliorate these symptoms, 10 patients with symptomatic endometr…

article 1989
Endometriosis as a Cause of Infertility
Obstetrics and gynecology clinics of North America ·doi:10.1016/s0889-8545(21)00139-x